PRESS RELEASES

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Erytech Pharma: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital –November 30, 2017
Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France --(BUSINESS WIRE)--Dec. 11, 2017-- Regulatory News : Erytech Pharma (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol : ERYP) &
View HTML
Toggle Summary Erytech Pharma: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital –November 30, 2017
Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France --(BUSINESS WIRE)--Dec. 11, 2017-- Regulatory News : Erytech Pharma (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol : ERYP) &
View HTML
Toggle Summary ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML
ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML Conference call and webcast to take place Monday, December 11th at 10:00 a.m. EST LYON, France - December 8, 2017 - ERYTECH Pharma (Euronext Paris: ERYP) (Nasdaq: ERYP) ("ERYTECH"), a clinical-stage
View HTML
Toggle Summary ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML
Conference call and webcast to take place Monday, December 11th at 10:00 a.m. EST LYON, France --(BUSINESS WIRE)--Dec. 8, 2017-- Regulatory News : ERYTECH Pharma (Euronext Paris: ERYP) (Nasdaq: ERYP) ("ERYTECH"), a clinical-stage biopharmaceutical company developing innovative therapies by
View HTML
Toggle Summary Erytech Pharma: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – November 16, 2017
Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France --(BUSINESS WIRE)--Nov. 16, 2017-- Regulatory News : Erytech Pharma (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol : ERYP) &
View HTML
Toggle Summary Erytech Pharma: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – November 16, 2017
Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France --(BUSINESS WIRE)--Nov. 16, 2017-- Regulatory News : Erytech Pharma (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol : ERYP) &
View HTML
Toggle Summary ERYTECH Announces Commencement of Trading of ADSs on Nasdaq and Full Exercise of Underwriters’ Option, Bringing Gross Proceeds of Global Offering to $144 Million
Base deal of $125 million in gross proceeds from specified categories of specialized investors closed on November 14, 2017 . Announced full exercise of underwriters’ option to purchase additional American Depositary Shares (ADSs) and Ordinary Shares, with closing expected to take place on or about
View HTML
Toggle Summary ERYTECH Announces Commencement of Trading of ADSs on Nasdaq and Full Exercise of Underwriters’ Option, Bringing Gross Proceeds of Global Offering to $144 Million
Base deal of $125 million in gross proceeds from specified categories of specialized investors closed on November 14, 2017 . Announced full exercise of underwriters’ option to purchase additional American Depositary Shares (ADSs) and Ordinary Shares, with closing expected to take place on or about
View HTML
Toggle Summary ERYTECH to Webcast Presentation at Jefferies 2017 London Healthcare Conference
LYON, France --(BUSINESS WIRE)--Nov. 14, 2017-- Regulatory News : ERYTECH Pharma (Nasdaq and Euronext : ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Gil Beyen , Chairman
View HTML
Toggle Summary ERYTECH to Webcast Presentation at Jefferies 2017 London Healthcare Conference
LYON, France --(BUSINESS WIRE)--Nov. 14, 2017-- Regulatory News : ERYTECH Pharma (Nasdaq and Euronext : ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Gil Beyen , Chairman
View HTML
Top